Free Trial

Kewaunee Scientific (KEQU) Competitors

Kewaunee Scientific logo
$38.16 +0.49 (+1.29%)
As of 12:29 PM Eastern
This is a fair market value price provided by Massive. Learn more.

KEQU vs. NAUT, LAB, OPTX, PRE, and MASS

Should you buy Kewaunee Scientific stock or one of its competitors? MarketBeat compares Kewaunee Scientific with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Kewaunee Scientific include Nautilus Biotechnology (NAUT), Standard BioTools (LAB), Syntec Optics (OPTX), Prenetics Global (PRE), and 908 Devices (MASS). These companies are all part of the "measuring and control equipment" industry.

How does Kewaunee Scientific compare to Nautilus Biotechnology?

Kewaunee Scientific (NASDAQ:KEQU) and Nautilus Biotechnology (NASDAQ:NAUT) are both small-cap measuring and control equipment companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, valuation, earnings, profitability, analyst recommendations, dividends, media sentiment and risk.

Kewaunee Scientific has a net margin of 3.85% compared to Nautilus Biotechnology's net margin of 0.00%. Kewaunee Scientific's return on equity of 18.09% beat Nautilus Biotechnology's return on equity.

Company Net Margins Return on Equity Return on Assets
Kewaunee Scientific3.85% 18.09% 6.71%
Nautilus Biotechnology N/A -35.04%-29.16%

Nautilus Biotechnology has a consensus target price of $4.00, suggesting a potential upside of 51.00%. Given Nautilus Biotechnology's higher possible upside, analysts clearly believe Nautilus Biotechnology is more favorable than Kewaunee Scientific.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Kewaunee Scientific
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00
Nautilus Biotechnology
1 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00

32.7% of Kewaunee Scientific shares are owned by institutional investors. Comparatively, 50.7% of Nautilus Biotechnology shares are owned by institutional investors. 13.3% of Kewaunee Scientific shares are owned by company insiders. Comparatively, 41.1% of Nautilus Biotechnology shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Kewaunee Scientific has a beta of 0.69, meaning that its share price is 31% less volatile than the broader market. Comparatively, Nautilus Biotechnology has a beta of 0.75, meaning that its share price is 25% less volatile than the broader market.

Kewaunee Scientific has higher revenue and earnings than Nautilus Biotechnology. Nautilus Biotechnology is trading at a lower price-to-earnings ratio than Kewaunee Scientific, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Kewaunee Scientific$240.47M0.46$11.40M$3.7210.26
Nautilus BiotechnologyN/AN/A-$59M-$0.46N/A

In the previous week, Kewaunee Scientific and Kewaunee Scientific both had 2 articles in the media. Nautilus Biotechnology's average media sentiment score of 1.44 beat Kewaunee Scientific's score of 1.31 indicating that Nautilus Biotechnology is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Kewaunee Scientific
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Nautilus Biotechnology
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

Kewaunee Scientific beats Nautilus Biotechnology on 7 of the 13 factors compared between the two stocks.

How does Kewaunee Scientific compare to Standard BioTools?

Kewaunee Scientific (NASDAQ:KEQU) and Standard BioTools (NASDAQ:LAB) are both small-cap measuring and control equipment companies, but which is the better business? We will contrast the two businesses based on the strength of their institutional ownership, profitability, earnings, analyst recommendations, valuation, risk, media sentiment and dividends.

In the previous week, Kewaunee Scientific had 1 more articles in the media than Standard BioTools. MarketBeat recorded 2 mentions for Kewaunee Scientific and 1 mentions for Standard BioTools. Standard BioTools' average media sentiment score of 1.87 beat Kewaunee Scientific's score of 1.31 indicating that Standard BioTools is being referred to more favorably in the news media.

Company Overall Sentiment
Kewaunee Scientific Positive
Standard BioTools Very Positive

Standard BioTools has a net margin of 73.46% compared to Kewaunee Scientific's net margin of 3.85%. Kewaunee Scientific's return on equity of 18.09% beat Standard BioTools' return on equity.

Company Net Margins Return on Equity Return on Assets
Kewaunee Scientific3.85% 18.09% 6.71%
Standard BioTools 73.46%-8.18%-6.43%

Kewaunee Scientific has a beta of 0.69, meaning that its stock price is 31% less volatile than the broader market. Comparatively, Standard BioTools has a beta of 1.32, meaning that its stock price is 32% more volatile than the broader market.

Standard BioTools has a consensus target price of $1.35, suggesting a potential upside of 33.00%. Given Standard BioTools' higher possible upside, analysts clearly believe Standard BioTools is more favorable than Kewaunee Scientific.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Kewaunee Scientific
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00
Standard BioTools
1 Sell rating(s)
2 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.67

32.7% of Kewaunee Scientific shares are held by institutional investors. Comparatively, 53.7% of Standard BioTools shares are held by institutional investors. 13.3% of Kewaunee Scientific shares are held by insiders. Comparatively, 23.2% of Standard BioTools shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Kewaunee Scientific has higher revenue and earnings than Standard BioTools. Standard BioTools is trading at a lower price-to-earnings ratio than Kewaunee Scientific, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Kewaunee Scientific$240.47M0.46$11.40M$3.7210.26
Standard BioTools$85.33M4.64-$74.90M$0.205.08

Summary

Kewaunee Scientific beats Standard BioTools on 8 of the 15 factors compared between the two stocks.

How does Kewaunee Scientific compare to Syntec Optics?

Syntec Optics (NASDAQ:OPTX) and Kewaunee Scientific (NASDAQ:KEQU) are both small-cap measuring and control equipment companies, but which is the superior stock? We will compare the two businesses based on the strength of their profitability, dividends, risk, earnings, analyst recommendations, valuation, media sentiment and institutional ownership.

Kewaunee Scientific has higher revenue and earnings than Syntec Optics. Syntec Optics is trading at a lower price-to-earnings ratio than Kewaunee Scientific, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Syntec Optics$28.08M9.77-$1.79M-$0.05N/A
Kewaunee Scientific$240.47M0.46$11.40M$3.7210.26

In the previous week, Syntec Optics and Syntec Optics both had 2 articles in the media. Kewaunee Scientific's average media sentiment score of 1.31 beat Syntec Optics' score of 1.30 indicating that Kewaunee Scientific is being referred to more favorably in the news media.

Company Overall Sentiment
Syntec Optics Positive
Kewaunee Scientific Positive

Syntec Optics has a beta of -0.93, meaning that its stock price is 193% less volatile than the broader market. Comparatively, Kewaunee Scientific has a beta of 0.69, meaning that its stock price is 31% less volatile than the broader market.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Syntec Optics
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Kewaunee Scientific
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

32.7% of Kewaunee Scientific shares are held by institutional investors. 0.8% of Syntec Optics shares are held by insiders. Comparatively, 13.3% of Kewaunee Scientific shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Kewaunee Scientific has a net margin of 3.85% compared to Syntec Optics' net margin of -6.38%. Kewaunee Scientific's return on equity of 18.09% beat Syntec Optics' return on equity.

Company Net Margins Return on Equity Return on Assets
Syntec Optics-6.38% -17.19% -7.14%
Kewaunee Scientific 3.85%18.09%6.71%

Summary

Kewaunee Scientific beats Syntec Optics on 12 of the 13 factors compared between the two stocks.

How does Kewaunee Scientific compare to Prenetics Global?

Kewaunee Scientific (NASDAQ:KEQU) and Prenetics Global (NASDAQ:PRE) are both small-cap measuring and control equipment companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, media sentiment, dividends, profitability, analyst recommendations, valuation, institutional ownership and earnings.

Kewaunee Scientific has higher revenue and earnings than Prenetics Global. Prenetics Global is trading at a lower price-to-earnings ratio than Kewaunee Scientific, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Kewaunee Scientific$240.47M0.46$11.40M$3.7210.26
Prenetics Global$92.39M3.16-$37.71M-$4.02N/A

In the previous week, Prenetics Global had 6 more articles in the media than Kewaunee Scientific. MarketBeat recorded 8 mentions for Prenetics Global and 2 mentions for Kewaunee Scientific. Kewaunee Scientific's average media sentiment score of 1.31 beat Prenetics Global's score of 0.69 indicating that Kewaunee Scientific is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Kewaunee Scientific
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Prenetics Global
2 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

32.7% of Kewaunee Scientific shares are owned by institutional investors. Comparatively, 25.0% of Prenetics Global shares are owned by institutional investors. 13.3% of Kewaunee Scientific shares are owned by insiders. Comparatively, 7.8% of Prenetics Global shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Kewaunee Scientific has a beta of 0.69, meaning that its stock price is 31% less volatile than the broader market. Comparatively, Prenetics Global has a beta of 0.15, meaning that its stock price is 85% less volatile than the broader market.

Prenetics Global has a consensus price target of $32.33, indicating a potential upside of 86.82%. Given Prenetics Global's stronger consensus rating and higher probable upside, analysts plainly believe Prenetics Global is more favorable than Kewaunee Scientific.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Kewaunee Scientific
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00
Prenetics Global
1 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.50

Kewaunee Scientific has a net margin of 3.85% compared to Prenetics Global's net margin of -61.33%. Kewaunee Scientific's return on equity of 18.09% beat Prenetics Global's return on equity.

Company Net Margins Return on Equity Return on Assets
Kewaunee Scientific3.85% 18.09% 6.71%
Prenetics Global -61.33%-19.61%-15.33%

Summary

Kewaunee Scientific beats Prenetics Global on 11 of the 16 factors compared between the two stocks.

How does Kewaunee Scientific compare to 908 Devices?

908 Devices (NASDAQ:MASS) and Kewaunee Scientific (NASDAQ:KEQU) are both small-cap measuring and control equipment companies, but which is the better investment? We will contrast the two businesses based on the strength of their dividends, media sentiment, earnings, institutional ownership, analyst recommendations, risk, valuation and profitability.

In the previous week, 908 Devices had 6 more articles in the media than Kewaunee Scientific. MarketBeat recorded 8 mentions for 908 Devices and 2 mentions for Kewaunee Scientific. Kewaunee Scientific's average media sentiment score of 1.31 beat 908 Devices' score of 0.48 indicating that Kewaunee Scientific is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
908 Devices
2 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Kewaunee Scientific
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

908 Devices has a beta of 0.57, meaning that its share price is 43% less volatile than the broader market. Comparatively, Kewaunee Scientific has a beta of 0.69, meaning that its share price is 31% less volatile than the broader market.

908 Devices has higher earnings, but lower revenue than Kewaunee Scientific. 908 Devices is trading at a lower price-to-earnings ratio than Kewaunee Scientific, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
908 Devices$56.20M5.00$19.49M-$1.00N/A
Kewaunee Scientific$240.47M0.46$11.40M$3.7210.26

Kewaunee Scientific has a net margin of 3.85% compared to 908 Devices' net margin of -62.40%. Kewaunee Scientific's return on equity of 18.09% beat 908 Devices' return on equity.

Company Net Margins Return on Equity Return on Assets
908 Devices-62.40% -14.03% -10.40%
Kewaunee Scientific 3.85%18.09%6.71%

908 Devices currently has a consensus price target of $12.00, indicating a potential upside of 61.51%. Given 908 Devices' higher possible upside, research analysts plainly believe 908 Devices is more favorable than Kewaunee Scientific.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
908 Devices
1 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00
Kewaunee Scientific
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

88.1% of 908 Devices shares are held by institutional investors. Comparatively, 32.7% of Kewaunee Scientific shares are held by institutional investors. 28.2% of 908 Devices shares are held by company insiders. Comparatively, 13.3% of Kewaunee Scientific shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Summary

Kewaunee Scientific beats 908 Devices on 8 of the 15 factors compared between the two stocks.

Get Kewaunee Scientific News Delivered to You Automatically

Sign up to receive the latest news and ratings for KEQU and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding KEQU and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

KEQU vs. The Competition

MetricKewaunee ScientificINSTRU IndustryComputer SectorNASDAQ Exchange
Market Cap$109.51M$1.17B$39.43B$12.47B
Dividend YieldN/A0.46%3.20%5.30%
P/E Ratio10.265.13164.9125.60
Price / Sales0.461.40622.9675.06
Price / Cash5.006.2447.8255.34
Price / Book1.643.029.566.71
Net Income$11.40M-$9.28M$1.03B$333.62M
7 Day Performance4.59%-2.73%0.39%0.32%
1 Month Performance10.88%5.57%9.59%4.06%
1 Year Performance2.95%6.35%164.62%36.29%

Kewaunee Scientific Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
KEQU
Kewaunee Scientific
1.0046 of 5 stars
$38.16
+1.3%
N/A+0.5%$109.51M$240.47M10.261,239
NAUT
Nautilus Biotechnology
3.7202 of 5 stars
$2.86
-1.0%
$4.00
+39.9%
+218.2%$367.26MN/AN/A130
LAB
Standard BioTools
3.1277 of 5 stars
$0.98
+4.7%
$1.35
+37.9%
-11.4%$364.99M$85.33MN/A620
OPTX
Syntec Optics
0.9489 of 5 stars
$7.68
-5.0%
N/A+355.4%$298.91M$28.08MN/A3
PRE
Prenetics Global
2.5634 of 5 stars
$16.73
+1.4%
$32.33
+93.3%
+228.4%$277.67M$92.39MN/A1

Related Companies and Tools


This page (NASDAQ:KEQU) was last updated on 5/14/2026 by MarketBeat.com Staff.
From Our Partners